These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 28693297

  • 21. Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs.
    King JN, Christinaz C, Strehlau G, Hornfeld J.
    J Vet Pharmacol Ther; 2018 Jun; 41(3):485-489. PubMed ID: 29392741
    [Abstract] [Full Text] [Related]

  • 22. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D, Fry D.
    Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
    [Abstract] [Full Text] [Related]

  • 23. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study.
    Chetboul V, Lefebvre HP, Sampedrano CC, Gouni V, Saponaro V, Serres F, Concordet D, Nicolle AP, Pouchelon JL.
    J Vet Intern Med; 2007 Nov; 21(4):742-53. PubMed ID: 17708394
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency.
    Kitagawa H, Wakamiya H, Kitoh K, Kuwahara Y, Ohba Y, Isaji M, Iwasaki T, Nakano M, Sasaki Y.
    J Vet Med Sci; 1997 Jul; 59(7):513-20. PubMed ID: 9271444
    [Abstract] [Full Text] [Related]

  • 25. Pimobendan in heart failure therapy--a silver bullet?
    Gordon SG, Miller MW, Saunders AB.
    J Am Anim Hosp Assoc; 2006 Jul; 42(2):90-3. PubMed ID: 16527909
    [Abstract] [Full Text] [Related]

  • 26. Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.
    King JN, Font A, Rousselot JF, Ash RA, Bonfanti U, Brovida C, Crowe ID, Lanore D, Pechereau D, Seewald W, Strehlau G.
    J Vet Intern Med; 2017 Jul; 31(4):1113-1122. PubMed ID: 28669137
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study).
    Summerfield NJ, Boswood A, O'Grady MR, Gordon SG, Dukes-McEwan J, Oyama MA, Smith S, Patteson M, French AT, Culshaw GJ, Braz-Ruivo L, Estrada A, O'Sullivan ML, Loureiro J, Willis R, Watson P.
    J Vet Intern Med; 2012 Jul; 26(6):1337-49. PubMed ID: 23078651
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the effects of long-term pimobendan and benazepril administration in normal cats.
    Miyagawa Y, Machida N, Toda N, Tominaga Y, Takemura N.
    J Vet Med Sci; 2016 Aug 01; 78(7):1099-106. PubMed ID: 26972332
    [Abstract] [Full Text] [Related]

  • 29. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S, Van Israël N, Vanbelle S, Clercx C, McEntee K.
    J Vet Pharmacol Ther; 2011 Aug 01; 34(4):322-31. PubMed ID: 20950346
    [Abstract] [Full Text] [Related]

  • 30. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
    Colfer HT, Ribner HS, Gradman A, Hughes CV, Kapoor A, Laidlaw JC.
    Am J Cardiol; 1992 Aug 01; 70(3):354-8. PubMed ID: 1632402
    [Abstract] [Full Text] [Related]

  • 31. A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs.
    Tenhündfeld J, Wefstaedt P, Nolte IJ.
    J Am Vet Med Assoc; 2009 Apr 15; 234(8):1031-7. PubMed ID: 19366333
    [Abstract] [Full Text] [Related]

  • 32. Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
    Yata M, Kooistra HS, Beijerink NJ.
    J Vet Intern Med; 2019 Mar 15; 33(2):462-470. PubMed ID: 30703246
    [Abstract] [Full Text] [Related]

  • 33. Compounded pimobendan for canine chronic degenerative mitral valve disease and pulmonary hypertension.
    Helms SR, Fox S, Mixon W, Vail J.
    Int J Pharm Compd; 2012 Mar 15; 16(1):34-41. PubMed ID: 23050309
    [Abstract] [Full Text] [Related]

  • 34. Concerns about "Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease".
    Corcoran B, Culshaw G, Dukes-McEwan J, French A, Smith S, Swift S.
    J Vet Intern Med; 2008 Mar 15; 22(2):243; author reply 245. PubMed ID: 18371020
    [No Abstract] [Full Text] [Related]

  • 35. Use of pimobendan in the management of heart failure.
    Fuentes VL.
    Vet Clin North Am Small Anim Pract; 2004 Sep 15; 34(5):1145-55. PubMed ID: 15325474
    [Abstract] [Full Text] [Related]

  • 36. Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.
    Sarcinella F, Neves J, Maddox TW, Hodgkiss-Geere HM, Bode EF, Dukes-McEwan J.
    Open Vet J; 2020 Jan 15; 9(4):375-383. PubMed ID: 32042661
    [Abstract] [Full Text] [Related]

  • 37. DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study.
    Borgarelli M, Ferasin L, Lamb K, Bussadori C, Chiavegato D, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M.
    J Vet Cardiol; 2020 Feb 15; 27():34-53. PubMed ID: 32032923
    [Abstract] [Full Text] [Related]

  • 38. Retrospective evaluation of a dose-dependent effect of angiotensin-converting enzyme inhibitors on long-term outcome in dogs with cardiac disease.
    Ward JL, Chou YY, Yuan L, Dorman KS, Mochel JP.
    J Vet Intern Med; 2021 Sep 15; 35(5):2102-2111. PubMed ID: 34387901
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C, Häggström J, Pedersen HD, Hansson K, Eriksson A, Järvinen AK, Tidholm A, Bsenko K, Ahlgren E, Ilves M, Ablad B, Falk T, Bjerkfås E, Gundler S, Lord P, Wegeland G, Adolfsson E, Corfitzen J.
    J Vet Intern Med; 2002 Sep 15; 16(1):80-8. PubMed ID: 11822810
    [Abstract] [Full Text] [Related]

  • 40. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL.
    J Vet Cardiol; 2011 Dec 15; 13(4):251-60. PubMed ID: 22030289
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.